Natera, Inc., a global leader in cell-free DNA testing, announced that it will release results for its fourth quarter and year ended December 31, 2021, after the market close on February 24, 2022.
AUSTIN, Texas, Feb. 17, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its fourth quarter and year ended December 31, 2021, after the market close on February 24, 2022. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.
| Earnings Conference Call Information: | |
| Event: | Natera’s Fourth Quarter and Year-End 2021 Financial Results |
| Date: | Thursday, February 24, 2022 |
| Time: | 1:30 p.m. PT (4:30 p.m. ET) |
| Live Dial-In: | (877) 823-0171, Domestic |
| (617) 500-6932, International | |
| Password: | 5675026 |
| Webcast: | |
| A webcast replay will be available at investor.natera.com. | |
About Natera
Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.
Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Kate Stabrawa, Communications, Natera, Inc., pr@natera.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/natera-announces-fourth-quarter-and-fiscal-2021-earnings-conference-call-301485352.html
SOURCE Natera, Inc.
Company Codes: NASDAQ-NMS:NTRA
